Davide Bonazzi
Illustrator
From this contributor
Company on brink takes psilocybin to trial for fragile X syndrome
The phase 2A trial has its detractors despite positive animal results and is being sponsored by a company that is struggling financially.
Company on brink takes psilocybin to trial for fragile X syndrome
Explore more from The Transmitter
Every neuroscience lab needs an ethicist
The ethics issues that arise in neuroscience research are usually novel, unresolved and understudied. Embedding ethicists in labs helps scientists navigate these challenges and develop strategies in real time to prevent harm.
Every neuroscience lab needs an ethicist
The ethics issues that arise in neuroscience research are usually novel, unresolved and understudied. Embedding ethicists in labs helps scientists navigate these challenges and develop strategies in real time to prevent harm.
Beyond glucose: The brain may feed itself
Myelin may serve as an energy reserve for the brain, according to recent findings, prompting neuroscientists to rethink how the brain stores, shares and protects energy.
Beyond glucose: The brain may feed itself
Myelin may serve as an energy reserve for the brain, according to recent findings, prompting neuroscientists to rethink how the brain stores, shares and protects energy.
SHANK3-variant effects in primates, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 25 May.
SHANK3-variant effects in primates, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 25 May.